Overview

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

Phase:

N/A

Details

Lead Sponsor:

Xijing Hospital

Treatments:

Atomoxetine Hydrochloride
Methylphenidate